News & Insights

The Headwinds of Specialty Drug Management

October 2020

As employers face multiple headwinds in managing specialty drug spend, traditional PBM models lack alignment and incentives to fully address these issues for their clients. Check out this insightful article published in JMCP and co-authored by our CEO Brenda Motheral on these challenges and the implications for plan sponsors working for a sustainable drug benefit.

Read White Paper
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×